With new Pod this week, we're re-releasing the 2nd episode from way back in 2017 that provides a historical overview of how the use of EGFR TKIs changed from their use in all NSLCLC to only with activating mutations.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
